Cytokinetics has revealed the results from a phase 3 trial of its hypertrophic cardiomyopathy (HCM) drug aficamten that it hopes will allow it to compete with Bristol-Myers Squibb’s first-to-market ...

Thank you for standing by, and welcome to the Cytokinetics Fourth Quarter 2025 Earnings Call. This call is being recorded. [Operator Instructions] I would now like to turn the call over to Diane ...

Abstract: Diazepam is an active ingredient of the drugs which is used in the treatment of the anxiety, insomnia, alcohol withdrawal, and muscle spasm. It has anxiolytic, sedative, muscle relaxant and ...